Status:
COMPLETED
Examining Brain Responses Linked to Emotion in Individuals Who Smoke Cigarettes
Lead Sponsor:
Penn State University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking, Tobacco
Eligibility:
All Genders
21-55 years
Phase:
NA
Brief Summary
The study will use functional magnetic resonance imaging and facial coding methods to study individuals who smoke cigarettes. Smoking expectancy (the extent to which one perceives an opportunity to sm...
Eligibility Criteria
Inclusion
- Participants must be between the ages of 21 and 55.
- Participants must be right handed.
- Participants must be fluent English speakers.
- Participants must report smoking at least 6 cigarettes per day continuously for at least the 12 preceding months.
- Participants must have a baseline expired air carbon monoxide (CO) exceeding a cutoff based upon prior research in order to verify smoking status.
Exclusion
- Individuals will be excluded if they report that they are actively trying to quit smoking.
- Individuals will be excluded if they report that they have had significant cardiovascular disease (such as heart disease, heart attack, stroke, or angina) or respiratory disease (such as asthma, chronic bronchitis, or COPD) during the past year.
- Individuals will be excluded if they report that they have used any of the following illicit substances more than 10 times in the previous 30 days: marijuana, cocaine, opiates such as heroin, methadone, benzodiazepines (such as Valium, Xanax), barbiturates, amphetamines, methamphetamines, PCP, LSD or any other hallucinogen.
- Individuals will be excluded if they report that they are currently taking prescription medications that previously have been found to affect blood flow responses in the brain.
- Individuals will be excluded if they have any known risk from exposure to high-field strength magnetic fields (e.g., pace makers), any irremovable metallic foreign objects in their body (e.g., braces), or a questionable history of metallic fragments that are likely to create artifact on the MRI scans.
- Individuals will be excluded if they meet criteria for current dependence on a substance other than nicotine based upon a brief structured interview.
- Individuals will be excluded if they report that they are not willing to refrain from using alcohol and recreational drugs for 24 hours and nicotine for 12 hours before the experimental lab visit.
- Individuals will be excluded if they currently use nicotine products other than cigarettes (e.g., chewing tobacco, snuff, e-cigarettes, or smoking cessation products).
- Individuals will be excluded if they are claustrophobic or are prone to becoming very uncomfortable in confined spaces.
- Individuals will be excluded if they report that they exclusively or primarily smoke "roll-your-own" cigarettes.
Key Trial Info
Start Date :
October 4 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 28 2023
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04310735
Start Date
October 4 2019
End Date
November 28 2023
Last Update
March 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Pennsylvania State University
University Park, Pennsylvania, United States, 16870